Picture loading failed.

Anti-ERBB2 therapeutic antibody (Pre-made Gancotamab biosimilar,scFv) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).

Gancotamab, an antibody directed nanotherapeutic that encapsulates doxorubicin in a HER2-targeted liposome, that was being developed by Merrimack.

Order informatioin


Delivery impact due to the Coronavirus Outbreak

With the COVID-19 outbreak in the world, many flights have been cancelled. In order for the customer to receive the goods properly, we use the FedEx Customized Freight (FCF) of Fedex which demands a higher fee. If the delivery fee is more expensive in your area, we will contact you by mail.

Catalog No. Package Price(In USD) Qty (Quantity) Sum(In USD)
GMP-Bios-ab-230-1mg 1mg 3090
GMP-Bios-ab-230-10mg 10mg 21890
GMP-Bios-ab-230-100mg 100mg 148000
GMP-Bios-ab-230-xmg ≥100mg Inquiry
Shipping Cost: 760.00
Total:



Description

Products Name (INN Index) Anti-ERBB2 therapeutic antibody (Pre-made Gancotamab biosimilar,scFv)
INN Name Gancotamab
TargetERBB2
FormatscFv
Derivation
Species ReactivityHuman
CH1 Isotypena
VD LCLambda
Highest_Clin_Trial (Jan '20)Phase-II
Est. StatusDiscontinued
100% SI StructureNone
99% SI StructureNone
95-98% SI StructureNone
Year Proposed2018
Year Recommended2019
CompaniesMerrimack Pharmaceuticals;HERMES BioSciences
Conditions Approvedna
Conditions Activena
Conditions DiscontinuedBreast cancer
Development Techna